Terms: = Lung cancer AND H3F3A, P84243, H3_3B, MGC87783, MGC87782, H3F3, H3_3A, ENSG00000163041, 3020 AND Diagnosis
8 results:
1. Multicentric Giant Cell Tumor of Bone.
Errani C; Tsukamoto S; Angulo Alvarado R; Righi A; Nitta Y; Donati DM; Mavrogenis AF
Orthopedics; 2023; 46(6):e376-e380. PubMed ID: 37126833
[TBL] [Abstract] [Full Text] [Related]
2. Malignant Transformation of Giant Cell Tumour of Bone: A Review of Literature and the Experience of a Referral Centre.
Vari S; Riva F; Onesti CE; Cosimati A; Renna D; Biagini R; Baldi J; Zoccali C; Anelli V; Annovazzi A; Covello R; Ascione A; Casini B; Ferraresi V
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142631
[TBL] [Abstract] [Full Text] [Related]
3. Chondroblastoma-like osteosarcoma: a clinicopathological and molecular study of a rare osteosarcoma variant.
Gaeta R; Righi A; Gambarotti M; Aretini P; Lessi F; Mazzanti CM; Mancini I; Pinzani P; Belgio B; Sbaraglia M; Tos APD; Franchi A
Histopathology; 2022 Sep; 81(3):389-401. PubMed ID: 35791778
[TBL] [Abstract] [Full Text] [Related]
4. h3f3a G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors.
Gong L; Bui MM; Zhang W; Sun X; Zhang M; Yi D
Histol Histopathol; 2021 Jan; 36(1):61-68. PubMed ID: 33021329
[TBL] [Abstract] [Full Text] [Related]
5. Detection of h3f3a p.G35W and p.G35R in giant cell tumor of bone by Allele Specific Locked Nucleic Acid quantitative PCR (ASLNAqPCR).
Gamberi G; Morandi L; Benini S; Resca A; Cocchi S; Magagnoli G; Donati DM; Righi A; Gambarotti M
Pathol Res Pract; 2018 Jan; 214(1):89-94. PubMed ID: 29254795
[TBL] [Abstract] [Full Text] [Related]
6. Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone.
Righi A; Mancini I; Gambarotti M; Picci P; Gamberi G; Marraccini C; Dei Tos AP; Simi L; Pinzani P; Franchi A
Hum Pathol; 2017 Oct; 68():128-135. PubMed ID: 28899740
[TBL] [Abstract] [Full Text] [Related]
7. h3f3a mutation in giant cell tumour of the bone is detected by immunohistochemistry using a monoclonal antibody against the G34W mutated site of the histone H3.3 variant.
Lüke J; von Baer A; Schreiber J; Lübbehüsen C; Breining T; Mellert K; Marienfeld R; Schultheiss M; Möller P; Barth TFE
Histopathology; 2017 Jul; 71(1):125-133. PubMed ID: 28211081
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of a clinic-based screening program for lung cancer with a case-control design in Kanagawa, Japan.
Okamoto N; Suzuki T; Hasegawa H; Gotoh T; Hagiwara S; Sekimoto M; Kaneko M
Lung Cancer; 1999 Aug; 25(2):77-85. PubMed ID: 10470841
[TBL] [Abstract] [Full Text] [Related]
